Summary
This Form 8-K filing from HCA Healthcare, Inc., dated February 6, 2014, primarily reports on significant changes to its Board of Directors and executive compensation. Specifically, four directors resigned effective February 1, 2014, and three new independent directors were appointed to the Board on the same date. These appointments result in a majority of the Board being independent, aligning with NYSE listing standards and the company's governance guidelines. Additionally, the filing discloses the approved base salaries for the newly appointed CEO, R. Milton Johnson ($1,100,000), and CFO, William B. Rutherford ($600,000), effective January 1, 2014. These executive compensation details are important for investors to understand the leadership's financial arrangements as the company moves forward. The company also announced these board changes via a press release on February 3, 2014.
Key Highlights
- 1HCA Healthcare announced the resignation of four directors: John P. Connaughton, Kenneth W. Freeman, Christopher R. Gordon, and James C. Momtazee, effective February 1, 2014.
- 2Three new independent directors were appointed to the Board: Nancy-Ann DeParle, John (Jack) W. Rowe, M.D., and Robert (Bob) J. Dennis, effective February 1, 2014.
- 3The appointment of new directors has resulted in a majority of the Board members being independent, in compliance with NYSE listing standards and HCA's Corporate Governance Guidelines.
- 4The Board size was reduced from fourteen to thirteen directors.
- 5The company approved annual base salaries for its new CEO, R. Milton Johnson, at $1,100,000, and its new CFO, William B. Rutherford, at $600,000, effective January 1, 2014.
- 6New directors Ms. DeParle and Dr. Rowe will serve on the Patient Safety and Quality of Care Committee.
- 7New director Mr. Dennis will serve on the Nominating and Corporate Governance Committee.